Sodium hydride → tert-Butyl [3-(2-methoxy-2-oxoethyl)-4,6-dimethyl-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl]acetate

HRID 1675755노트

반응식

HRID 1675755 반응식
[CH3:1][C:2]1[C:10]2[NH:9][C:8](=[O:11])[N:7]([CH2:12][C:13]([O:15][C:16]([CH3:19])([CH3:18])[CH3:17])=[O:14])[C:6]=2[CH:5]=[C:4]([CH3:20])[CH:3]=1.[H-].[Na+].Br[CH2:24][C:25]([O:27][CH3:28])=[O:26]>CN(C=O)C>[C:16]([O:15][C:13](=[O:14])[CH2:12][N:7]1[C:6]2[CH:5]=[C:4]([CH3:20])[CH:3]=[C:2]([CH3:1])[C:10]=2[N:9]([CH2:24][C:25]([O:27][CH3:28])=[O:26])[C:8]1=[O:11])([CH3:17])([CH3:19])[CH3:18]

참가 물질

5

반응물 3

HCID 24758Sodium hydrideHCID 60984Methyl bromoacetateHCID 86607783tert-Butyl (4,6-dimethyl-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)acetate

생성물 1

HCID 86607784tert-Butyl [3-(2-methoxy-2-oxoethyl)-4,6-dimethyl-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl]acetate

시약·촉매·용매 1

HCID 6228Dimethylformamide용매

실험 절차

To a solution of tert-butyl (4,6-dimethyl-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)acetate from Step B (100 mg, 0.36 mmol) in DMF (3 mL) was added sodium hydride (17 mg of a 60% dispersion in mineral oil, 0.43 mmol) followed by methyl bromoacetate (0.041 mL, 0.43 mmol) and the reaction mixture was stirred for 2 h. The reaction was purified directly by HPLC using a reversed phase C18 column and eluting with a gradient of H2O:CH3CN:CF3CO2H-90:10:0.1 to 5:95:0.1. Lyophilization of the product-containing fractions afforded the title compound. MS: m/z=349 (M+1).

후처리

  1. customThe reaction was purified directly by HPLC
  2. washeluting with a gradient of H2O

출처 및 근거

ORD 기록
ord-9bdff6d2c3354e39b66d1664df86e97f
출처 데이터셋
uspto-grants-2011_08
특허 번호
US08003792B2

반응 노트

불러오는 중…